CPhI Worldwide 2019

Integrating the patient’s voice into drug delivery systems

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Chinnapong)
(Image: Getty/Chinnapong)

Related tags: delivery, Drug delivery systems, Drug delivery, Drug delivery technologies, Drug delivery technology, Patient centricity, Insulin, Diabetes, West pharmaceutical services, West

While exhibiting its offering in self-administration devices at the CPhI Worldwide event in Frankfurt last week, West told us how patient convenience drives design and development.

In a time when the increasing prevalence of chronic diseases boosts the sales of self-administration devices​ and patient centricity has become one of the main topics of discussion​ across the various sectors of the industry, in-PharmaTechnologist spoke with Mike Schaefers, VP and GM for global pharma at West Pharmaceutical Services, about how the company is trying to answer current market needs.

“The challenge in the manufacture of self-administration devices comes as every patient is different, and every treatment, every new therapy that comes to market is different, and requires different administration,”​ Schaefers told us.

According to the executive, drug delivery methods are increasingly tailored around patients’ needs, and “[the] voice of the customer is now more than ever integrated in the development and optimization” ​of the devices.

Schaefers brought up the example of diabetes medication, which “half of the patients do not take, because they find it disturbing and painful. The current trend in the industry is ease of use and convenience,” ​he noted, adding that insurance companies also encourage this trend, by ‘demanding performance’.

Digitally-enabled devices ‘still in infancy’

Especially regarding diabetes, the company also looks to follow the ongoing industry trend that encourages developers to integrate digital technology​ to optimize dosage and biomarkers’ monitoring and, ultimately, disease management.

“Our devices offer opportunities to connect devices with smartphones, and we also develop applications that support this connection,” ​Schaefers noted.

However, the executive expressed the opinion that digitalization of care, in general, is ‘in its infancy’.

“I think we are still looking at solutions for all patients, even elderly patients who might not be so comfortable with digital technology. It is definitely a trend going forward, but it will take some time,”​ he said.

Related topics: Drug Delivery, Delivery technologies

Related news

Show more

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us


View more